All Pharma News
price-trendAsk Us
Outcome Capital Announces Acquisition of Propella Therapeutics

Outcome Capital Announces Acquisition of Propella Therapeutics
BUSINESSWIRE
04 Jan 2024
Share Share
Astellas completes acquisition of Propella Therapeutics

Astellas completes acquisition of Propella Therapeutics
INDIAN PHARMA POST
26 Dec 2023
Share Share
Astellas to Acquire Propella Therapeutics

Astellas to Acquire Propella Therapeutics
PR NEWSWIRE
15 Nov 2023
Share Share
Propella Announces Presentation of Ph1/2a Data of PRL-02 for Prostate Cancer

Propella Announces Presentation of Ph1/2a Data of PRL-02 for Prostate Cancer
GLOBENEWSWIRE
14 Feb 2023
Share Share
Propella Therapeutics Announces Presentation of Phase 1/2 Data of PRL-02

Propella Therapeutics Announces Presentation of Phase 1/2 Data of PRL-02
GLOBENEWSWIRE
08 Sep 2022
Share Share
Propella Tx Signs Licensing Agreement with Jiangsu Aosaikang Pharmaceutical

Propella Tx Signs Licensing Agreement with Jiangsu Aosaikang Pharmaceutical
GLOBENEWSWIRE
07 Apr 2022
Share Share
Propella Announces First Patient Dosed in Phase 1/2a Trial of PRL-02

Propella Announces First Patient Dosed in Phase 1/2a Trial of PRL-02
GLOBENEWSWIRE
29 Jun 2021
Share Share
Propella Therapeutics Receives FDA Clearance to Begin Phase 1 Clinical Study

Propella Therapeutics Receives FDA Clearance to Begin Phase 1 Clinical Study
PRNEWSWIRE
18 May 2021
Share Share
Propella Therapeutics Partners with National Cancer Institute to Develop New

Propella Therapeutics Partners with National Cancer Institute to Develop New
PRNEWSWIRE
23 Feb 2021
Share Share